Activity of a 40kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma

By Chagnovich D.   Cohn S.L.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2064-2067

Elsevier

Access to resources Recommend Favorite

Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma

By Kramer K.   Cheung N.-K.V.   Gerald W.L.   LaQuaglia M.   Kushner B.H.   LeClerc J.-M.   LeSauter L.   Saragovi H.U.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2098-2100

Elsevier

Access to resources Recommend Favorite

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

By Combaret V.   Gross N.   Lasset C.   Frappaz D.   Beretta-Brognara C.   Philip T.   Beck D.   Favrot M.C.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2101-2105

Elsevier

Access to resources Recommend Favorite

Mechanisms of in vivo antineuroblastoma activity of human natural IgM

By Ollert M.W.   David K.   Vollmert C.   Juhl H.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1942-1948

Elsevier

Access to resources Recommend Favorite

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite